Lord, Abbett & Co. LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Lord, Abbett & Co. LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$83.14 - $145.99 $11.3 Million - $19.8 Million	-135,673 Reduced 29.94%	317,429 $46.3 Million
Q1 2022 May 13, 2022	BUY	$110.08 - $142.92 $19.2 Million - $25 Million	174,775 Added 62.79%	453,102 $53.7 Million
Q4 2021 Feb 11, 2022	BUY	$99.73 - $148.48 $17.8 Million - $26.5 Million	178,327 Added 178.33%	278,327 $38.4 Million
Q3 2021 Nov 09, 2021	BUY	$98.85 - $138.91 $9.89 Million - $13.9 Million	100,000 New	100,000 $13.9 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.